Chungcheongbuk-do, South Korea

Kyung Suk Cho

This inventor holds 1 USPTO granted patent. Top assignee: Celltrion Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyung Suk Cho. Retrieved from https://idiyas.com/inventor/kyung-suk-cho-ui081j1m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kyung Suk Cho and Pharmaceutical Formulation Innovation.

Introduction

Kyung Suk Cho is an inventor associated with Chungcheongbuk-do, South Korea. His patent work includes a pharmaceutical formulation designed to provide both immediate and extended release of cibenzoline.

Latest Patents

The supplied information identifies one patent for Cho: “Pharmaceutical Formulation Comprising Cibenzoline or Salt Thereof.” The formulation combines an immediate-release layer with an extended-release layer to create a biphasic dissolution profile. This design aims to bring cibenzoline to an effective plasma concentration quickly and maintain that concentration over time, potentially allowing the medicine to be administered once daily. The record lists 1 patent.

Career Highlights

Cho is associated with Celltrion Inc. His listed patent reflects work on drug-delivery design, with a focus on balancing an early release of medication with sustained release later.

Collaborations

GuK Bin Park and Jae Hun Song are identified as Cho’s coworkers. The supplied information does not specify their roles in the patent or the extent of their collaboration.

Conclusion

Kyung Suk Cho’s listed patent centers on a once-daily cibenzoline formulation intended to provide both rapid onset and sustained drug release.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…